Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ab...
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1,000 molecules, covering all major therapeutic areas, accounted for 2017 sales of USD 10.1 billion. In 2017, our products reached well over 500 million patients. Sandoz is headquartered in Holzkirchen, in Germany's Greater Munich area.
Sandoz is also on Twitter. Follow us on @Sandoz_global and Facebook: https://www.facebook.com/sandozglobal/
See the Sandoz community guidelines: https://www.sandoz.com/sites/www.sandoz.com/files/sandoz-social-media-community-guidelines.pdf
Sandoz Pharmaceuticals is a pharmaceuticals company manufacturing generic pharmaceuticals.
The company is a division of Novartis International. In addition to its retail generics drugs, Sandoz also operates in opthalmics, respiratory, anti-infectives, dermatology and the biopharmaceuticals business. The company is the third-largest division of Novartis, representing around 15% of the Group’s total net sales.
The company employees over 26,000 people around the world and maintains its headquarters in Holzkirchen, Germany.
The company was founded in 1886 in Basel.